vs
Nextpower Inc.（NXT）とSurgery Partners, Inc.（SGRY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Nextpower Inc.の直近四半期売上が大きい（$909.4M vs $885.0M、Surgery Partners, Inc.の約1.0倍）。Nextpower Inc.の純利益率が高く（14.4% vs -1.7%、差は16.1%）。Nextpower Inc.の前年同期比売上増加率が高い（33.9% vs 2.4%）。Nextpower Inc.の直近四半期フリーキャッシュフローが多い（$118.5M vs $90.6M）。過去8四半期でNextpower Inc.の売上複合成長率が高い（11.1% vs 11.1%）
Nextpower Inc（証券コード：NXT）は米国カリフォルニア州フリーモントに本社を置くグローバルなエネルギーテクノロジー企業です。世界中の顧客に最先端のエネルギー技術ソリューションと関連サービスを提供し、同分野で高い技術力と市場競争力を有しています。
Surgery Partners, Inc.（NASDAQ：SGRY）傘下のUnited Surgical Partners International（USPI）は米国テキサス州ダラスに本拠を置く外来手術医療サービス企業で、1998年にドン・スティーンにより設立されました。複数の外来手術センターを運営し、米国各地の患者に質の高い効率的な外来外科医療を提供しています。
NXT vs SGRY — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $909.4M | $885.0M |
| 純利益 | $131.2M | $-15.0M |
| 粗利率 | 31.7% | — |
| 営業利益率 | 19.4% | 12.5% |
| 純利益率 | 14.4% | -1.7% |
| 売上前年比 | 33.9% | 2.4% |
| 純利益前年比 | 13.8% | 86.2% |
| EPS（希薄化後） | $0.85 | $-0.11 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $909.4M | $885.0M | ||
| Q3 25 | $905.3M | $821.5M | ||
| Q2 25 | $864.3M | $826.2M | ||
| Q1 25 | $924.3M | $776.0M | ||
| Q4 24 | $679.4M | $864.4M | ||
| Q3 24 | $635.6M | $770.4M | ||
| Q2 24 | $719.9M | $762.1M | ||
| Q1 24 | $736.5M | $717.4M |
| Q4 25 | $131.2M | $-15.0M | ||
| Q3 25 | $146.9M | $-22.7M | ||
| Q2 25 | $157.2M | $-2.5M | ||
| Q1 25 | $156.8M | $-37.7M | ||
| Q4 24 | $115.3M | $-108.5M | ||
| Q3 24 | $115.4M | $-31.7M | ||
| Q2 24 | $121.7M | $-15.5M | ||
| Q1 24 | $205.2M | $-12.4M |
| Q4 25 | 31.7% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.6% | — | ||
| Q1 25 | 33.1% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.4% | — | ||
| Q2 24 | 33.0% | — | ||
| Q1 24 | 46.2% | — |
| Q4 25 | 19.4% | 12.5% | ||
| Q3 25 | 20.0% | 12.9% | ||
| Q2 25 | 21.5% | 13.5% | ||
| Q1 25 | 21.1% | 8.0% | ||
| Q4 24 | 22.1% | 14.7% | ||
| Q3 24 | 21.0% | 7.9% | ||
| Q2 24 | 22.2% | 11.1% | ||
| Q1 24 | 36.8% | 10.6% |
| Q4 25 | 14.4% | -1.7% | ||
| Q3 25 | 16.2% | -2.8% | ||
| Q2 25 | 18.2% | -0.3% | ||
| Q1 25 | 17.0% | -4.9% | ||
| Q4 24 | 17.0% | -12.6% | ||
| Q3 24 | 18.2% | -4.1% | ||
| Q2 24 | 16.9% | -2.0% | ||
| Q1 24 | 27.9% | -1.7% |
| Q4 25 | $0.85 | $-0.11 | ||
| Q3 25 | $0.97 | $-0.18 | ||
| Q2 25 | $1.04 | $-0.02 | ||
| Q1 25 | $1.05 | $-0.30 | ||
| Q4 24 | $0.79 | $-0.86 | ||
| Q3 24 | $0.79 | $-0.25 | ||
| Q2 24 | $0.84 | $-0.12 | ||
| Q1 24 | $1.52 | $-0.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $952.6M | $239.9M |
| 総負債低いほど良い | — | $3.6B |
| 株主資本純資産 | $2.2B | $1.7B |
| 総資産 | $3.8B | $8.1B |
| 負債/資本比率低いほどレバレッジが低い | — | 2.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $952.6M | $239.9M | ||
| Q3 25 | $845.3M | $203.4M | ||
| Q2 25 | $743.4M | $250.1M | ||
| Q1 25 | $766.1M | $229.3M | ||
| Q4 24 | $693.5M | $269.5M | ||
| Q3 24 | $561.9M | $221.8M | ||
| Q2 24 | $471.9M | $213.5M | ||
| Q1 24 | $474.1M | $185.2M |
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.5B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $1.8B | $1.7B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.3B | $1.9B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $961.0M | $2.0B |
| Q4 25 | $3.8B | $8.1B | ||
| Q3 25 | $3.7B | $7.9B | ||
| Q2 25 | $3.4B | $8.0B | ||
| Q1 25 | $3.2B | $7.9B | ||
| Q4 24 | $3.0B | $7.9B | ||
| Q3 24 | $2.8B | $7.5B | ||
| Q2 24 | $2.6B | $7.5B | ||
| Q1 24 | $2.5B | $7.0B |
| Q4 25 | — | 2.10× | ||
| Q3 25 | — | 2.00× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 1.98× | ||
| Q4 24 | — | 1.83× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | — | 1.42× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.3M | $103.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $118.5M | $90.6M |
| FCFマージンFCF / 売上 | 13.0% | 10.2% |
| 設備投資強度設備投資 / 売上 | 0.5% | 1.4% |
| キャッシュ転換率営業CF / 純利益 | 0.94× | — |
| 直近12ヶ月FCF直近4四半期 | $587.3M | $195.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.3M | $103.4M | ||
| Q3 25 | $186.9M | $83.6M | ||
| Q2 25 | $81.3M | $81.3M | ||
| Q1 25 | $237.3M | $6.0M | ||
| Q4 24 | $143.8M | $111.4M | ||
| Q3 24 | $153.8M | $65.2M | ||
| Q2 24 | $120.8M | $82.8M | ||
| Q1 24 | $111.5M | $40.7M |
| Q4 25 | $118.5M | $90.6M | ||
| Q3 25 | $171.4M | $63.8M | ||
| Q2 25 | $70.1M | $57.9M | ||
| Q1 25 | $227.2M | $-16.7M | ||
| Q4 24 | $134.9M | $89.1M | ||
| Q3 24 | $141.8M | $45.0M | ||
| Q2 24 | $118.0M | $55.9M | ||
| Q1 24 | $109.2M | $19.7M |
| Q4 25 | 13.0% | 10.2% | ||
| Q3 25 | 18.9% | 7.8% | ||
| Q2 25 | 8.1% | 7.0% | ||
| Q1 25 | 24.6% | -2.2% | ||
| Q4 24 | 19.9% | 10.3% | ||
| Q3 24 | 22.3% | 5.8% | ||
| Q2 24 | 16.4% | 7.3% | ||
| Q1 24 | 14.8% | 2.7% |
| Q4 25 | 0.5% | 1.4% | ||
| Q3 25 | 1.7% | 2.4% | ||
| Q2 25 | 1.3% | 2.8% | ||
| Q1 25 | 1.1% | 2.9% | ||
| Q4 24 | 1.3% | 2.6% | ||
| Q3 24 | 1.9% | 2.6% | ||
| Q2 24 | 0.4% | 3.5% | ||
| Q1 24 | 0.3% | 2.9% |
| Q4 25 | 0.94× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 1.25× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | 0.54× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |
